KK Shiseido header image

KK Shiseido

4911

Equity

ISIN JP3351600006 / Valor 763285

Tokyo Stock Exchange (2024-11-20)
JPY 2,740.50+0.37%

KK Shiseido
UMushroom community rating:

star star star star star
4.43 7 votes No rating yet
NegativeNeutralPositive

About company

KK Shiseido, established in 1872 in Ginza, Tokyo, began as Japan's first Western-style pharmacy and has since evolved into a leading global beauty company. Operating in approximately 120 countries and regions, Shiseido is renowned for its innovative approach to beauty and skincare, consistently setting industry standards with its pioneering products. The company focuses on creating unique beauty solutions that transcend traditional cosmetics, aiming to deliver new values and enhance customer satisfaction worldwide. With a strong foundation in Japan, Shiseido continues to expand its influence and offerings, maintaining a steadfast commitment to innovation and excellence in the beauty industry.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (07.08.2024):

Q1 2024 Revenue Growth

KK Shiseido reported a year-over-year net sales growth of 3% on a like-for-like basis in Q1 2024. This growth was achieved despite challenges such as treated water release effects and inventory adjustments in the China and Travel Retail Businesses.

Core Operating Profit

In Q1 2024, KK Shiseido achieved a core operating profit of JPY 11.3 billion. This was a significant milestone, reflecting the company's successful implementation of structural reforms and strategic marketing investments.

Japan Business Performance

KK Shiseido's Japan Business saw accelerated growth in Q1 2024, with core brands achieving growth in the high 20% range and hero products exceeding 30% growth. This performance was driven by increased market share and effective sales generation through balanced investment allocation.

China Market Share

In Q1 2024, KK Shiseido increased its market share in the prestige category in China. This was attributed to strategic marketing investments aimed at maximizing market recovery and capturing consumer interest in high-end products.

E-commerce Growth

KK Shiseido's e-commerce sales in Q1 2024 grew significantly, reaching the high 20% range. This marked a substantial acceleration from the lower 10% growth seen in FY2023, driven by strategic plans to strengthen Retail.com, expand into Pure Players, and enhance Owned.com platforms.

Summarized from source with an LLMView Source

Key figures

-36.6%1Y
-63.1%3Y
-65.7%5Y

Performance

43.2%1Y
35.5%3Y
34.0%5Y

Volatility

Market cap

7058 M

Market cap (USD)

Daily traded volume (Shares)

2,043,600

Daily traded volume (Shares)

1 day high/low

2782 / 2710

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.43

7 votes
Performance:
starstarstarstarstar
4.29
Innovation:
starstarstarstarstar
4.14
Society:
starstarstarstarstar
4.14
Nature:
starstarstarstarstar
4.14
Robin Roten
Switzerland, 19 Dec 2022
star star star star star
Joseph WI Gospodinov
Switzerland, 05 Jul 2022
star star star star star
Thomas Swiatek
Switzerland, 04 Jul 2022
star star star star star
Good company with high brand value. Definitely one of the more interesting Kabushiki Gaishas!

EQUITIES OF THE SAME SECTOR

Towa Yakuhin KK
Towa Yakuhin KK Towa Yakuhin KK Valor: 248084
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.32%JPY 2,827.00
Verona Pharma PLC
Verona Pharma PLC Verona Pharma PLC Valor: 36485349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.00%USD 38.85
RadNet Inc
RadNet Inc RadNet Inc Valor: 2812237
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.89%USD 82.16
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.53%USD 40.14
Opko Health Inc
Opko Health Inc Opko Health Inc Valor: 3094438
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.47%USD 1.58
LeMaitre Vascular inc
LeMaitre Vascular inc LeMaitre Vascular inc Valor: 2755054
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.29%USD 103.44
AMEDISYS Inc
AMEDISYS Inc AMEDISYS Inc Valor: 399513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 90.00
Revance Therapeutics Inc
Revance Therapeutics Inc Revance Therapeutics Inc Valor: 23239569
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%USD 3.80
Corcept Therapeutics Inc
Corcept Therapeutics Inc Corcept Therapeutics Inc Valor: 1812837
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.29%USD 56.09
Revolution Medicines Inc
Revolution Medicines Inc Revolution Medicines Inc Valor: 52143299
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.06%USD 57.07